MycoShell
A living, radiation-shielding structural habitat shell, grown from local regolith. The flagship and the critical path.
Mission
Space-native life support, grown not launched.
We build radiotrophic biomaterials for in-situ construction, shelf-stable biology that keeps crews healthy, and the computational platform that tells us what to test next.
Two independently validated research threads, radiotrophic melanin biology and grown mycelium structure, had never been combined into one product. That is the company.
What we build
Three platforms.
Crew-health biology
Fourteen shelf-stable probiotic, peptide, exosome and nutrition products, designed to work without refrigeration.
Cosmion
A computational biology platform for cited evidence, strain safety, peptide design and mission simulation, with uncertainty on every prediction.
Business model
Three revenue streams, one grown material.
Near-term agency contracts fund the ISS structural demo; mid-term habitat licensing turns that into recurring space revenue; long-term terrestrial licensing captures upside independent of the space industry's pace.
01
Agency contracts
Milestone-based development and flight-demo contracts with space agencies, building on NASA's own NIAC investment in the underlying science.
02
Habitat licensing
Recurring licensing of structural-shell and shielding material to commercial LEO stations and lunar module builders.
03
Terrestrial materials
Out-licensing the grown mycelium composite into sustainable construction, with no space contract required.
Mission
Biology for life beyond Earth.
3platforms: MycoShell, crew-health biology, Cosmion
Team
The team we are building.
Founding roles this programme closes. Named hires and advisors to be announced.
Aeginis
Chief Scientific OfficerMycology and extremophile biology; leads the radiotrophic strain programme
Head of Materials EngineeringStructural composites and habitat integration with regolith simulants
Head of Spaceflight OperationsAgency relationships, payload integration, flight-safety certification
Computational Biology LeadEvidence, strain and peptide modelling on the Cosmion platform
Advisory boardRadiotrophic fungi research, NASA NIAC habitat engineering, space-programme business development
Roadmap
Where we are going.
Programme
Three-year path
Year 1
Year 2
Year 3+
MycoShell
Ground and small orbital coupon tests
ISS National Lab structural and shielding demo
Lunar Gateway or commercial station pilot
Radioprotective probiotic
Parked at TRL 1: advances only if MycoShell milestones are funded ahead of schedule
Platform
Cosmion phases
Phase 1
Phase 2
Phase 3
Phase 4
Cosmion
Evidence and ranking
Strains and peptides
Simulation and planning
Closed loop
Partnerships
Built with partners.
We work with Theertha Biopharma on peptides and biologics, so computational designs are checked against what can actually be manufactured.
We welcome space agencies, research institutes and commercial station operators for research collaboration, flight payloads and licensing.
Let's build the next shield together.
Space agencies, station builders, research institutes and sustainable-construction partners: we would like to hear from you.